Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifevantage (LFVN) EBITDA (2016 - 2025)

Lifevantage (LFVN) has disclosed EBITDA for 16 consecutive years, with $17000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 99.09% year-over-year to $17000.0, compared with a TTM value of $8.1 million through Dec 2025, up 19.68%, and an annual FY2025 reading of $10.5 million, up 342.74% over the prior year.
  • EBITDA was $17000.0 for Q4 2025 at Lifevantage, down from $2.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $4.9 million in Q2 2021 and bottomed at -$2.0 million in Q2 2022.
  • Average EBITDA over 5 years is $1.3 million, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw EBITDA crashed 318.0% in 2022, then soared 1068.91% in 2024.
  • Year by year, EBITDA stood at -$100000.0 in 2021, then plummeted by 318.0% to -$418000.0 in 2022, then skyrocketed by 53.83% to -$193000.0 in 2023, then skyrocketed by 1068.91% to $1.9 million in 2024, then plummeted by 99.09% to $17000.0 in 2025.
  • Business Quant data shows EBITDA for LFVN at $17000.0 in Q4 2025, $2.0 million in Q3 2025, and $2.3 million in Q2 2025.